Analysis of the Ranbaxy Lab stock that is listed on BSE/NSE. Includes return ratios and piotroski scores to understand financial stability of the stocks

1. Ranbaxy Laboratories
BSE Code : 500359
NSE Code : RANBAXY
Sector : PHARMACEUTICALS
Report date : Sun Apr 13 10:42:01 EDT 2014
Industry overview
Market Cap
Market Cap is the price of
all the outstanding
common shares if we were
to buy it all at the current
price
19828.62 Cr
The benchmark company
Sun Pharma in the
pharmaceuticals sector is
7 times the size of
Ranbaxy Laboratories
Large Caps are a choice
for people who want Low
volatility/risk with stable
returns and high liquidity
1

2. Stock Analysis
Growth Analysis
Companies that have grown historically are more likely to exibit similar growth in the future. Read
the trends in the 4 year annualized profit growth, book value growth and sales growth shown
below:
How good are the returns?
RoE is the speed at which the company might grow without sorting to additional fund raising.
RoCE is the growth speed, if the company used all the assets, including loans/preference shares.
The 2-year and 4-year values give a reasonable assurance about the growth sustenance.
KEY
KEY
2

3. Piotroski Score
Seperate Winners from Losers
The Piotroski scoring system is a nine point system to determine the strength of a firm's financial
position. The score was developed by an accounting professor out of Chicago named Joseph
Piotroski. If it scores an 8 or 9, then the fundamentals are great for the stock.
Score: 4/9
3